Balance Sheet - Mineralys Therapeutics, Inc. (MLYS)
$(Billion, Million)| Dec-25 | Dec-24 | Dec-23 | Dec-22 | Dec-21 | Dec-20 | |
|---|---|---|---|---|---|---|
| Total cash and short-term investments | 656.64 | 198.19 | 236.57 | 110.11 | 10.61 | 1.41 |
| Other current assets | 4.75 | 7.16 | 12.54 | 2.70 | 0.51 | 0.06 |
| Total current assets | 661.39 | 205.35 | 249.10 | 112.81 | 11.12 | 1.47 |
| Total non-current assets | 0.42 | 0.55 | 2.53 | 1.63 | 0.00 | 0.02 |
| Total assets | 661.81 | 205.90 | 251.64 | 114.44 | 11.13 | 1.49 |
| Total current liabilities | 15.11 | 14.65 | 10.48 | 8.07 | 5.05 | 5.08 |
| Total non-current liabilities | 0.00 | 0.00 | 0.00 | 158.64 | 29.00 | 0.00 |
| Total liabilities | 15.11 | 14.65 | 10.48 | 166.71 | 34.05 | 5.08 |
| Total stockholders' equity | 646.69 | 191.26 | 241.15 | -52.27 | -22.93 | -3.60 |
| Common shares outstanding | 68 | 49 | 36 | 5 | 5 | 5 |
Show Quarterly Balance Sheet
Balance Sheet - Mineralys Therapeutics, Inc. (MLYS)
$(Billion, Million)| Mar-26 | Dec-25 | Sep-25 | Jun-25 | Mar-25 | Dec-24 | Sep-24 | Jun-24 | Mar-24 | Dec-23 | Sep-23 | Jun-23 | Mar-23 | Dec-22 | Sep-22 | Jun-22 | Mar-22 | Dec-21 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total cash and short-term investments | 646.06 | 656.64 | 593.63 | 324.92 | 343.03 | 198.19 | 263.60 | 311.12 | 338.57 | 236.57 | 253.76 | 261.10 | 270.64 | 110.11 | 120.95 | 0.00 | 10.61 | 10.61 |
| Other current assets | 6.41 | 4.75 | 382.20 | 10.35 | 11.48 | 7.16 | 4.13 | 6.89 | 8.25 | 12.54 | 11.61 | 8.39 | 4.64 | 2.70 | 0.93 | 0.51 | ||
| Total current assets | 652.47 | 661.39 | 599.80 | 335.27 | 354.51 | 205.35 | 267.73 | 318.00 | 346.82 | 249.10 | 265.38 | 269.49 | 275.27 | 112.81 | 121.89 | 10.61 | 11.12 | |
| Total non-current assets | 0.39 | 0.42 | 0.15 | 0.46 | 0.44 | 0.55 | 0.52 | 0.49 | 0.43 | 2.53 | 12.18 | 21.73 | 31.16 | 1.63 | 0.56 | -10.61 | 0.00 | |
| Total assets | 652.86 | 661.81 | 599.95 | 335.72 | 354.94 | 205.90 | 268.25 | 318.49 | 347.25 | 251.64 | 277.56 | 291.22 | 306.44 | 114.44 | 122.45 | 11.13 | ||
| Total current liabilities | 14.72 | 15.11 | 23.52 | 22.17 | 13.39 | 14.65 | 31.32 | 28.40 | 19.20 | 10.48 | 13.54 | 6.21 | 10.56 | 8.07 | 7.22 | 5.05 | ||
| Total non-current liabilities | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 158.64 | 158.64 | 29.00 | ||
| Total liabilities | 14.72 | 15.11 | 23.52 | 22.17 | 13.39 | 14.65 | 31.32 | 28.40 | 19.20 | 10.48 | 13.54 | 6.21 | 10.56 | 166.71 | 165.86 | 34.05 | ||
| Total stockholders' equity | 638.14 | 646.69 | 576.43 | 313.55 | 341.56 | 191.26 | 236.93 | 290.10 | 328.05 | 241.15 | 264.01 | 285.01 | 295.88 | -52.27 | -43.41 | 6.07 | -22.93 | |
| Common shares outstanding | 83 | 81 | 71 | 65 | 53 | 50 | 50 | 49 | 45 | 40 | 40 | 40 | 25 | 5 | 5 | 5 | 5 | 5 |